Therapeutic Kinase Inhibitors
Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as “chemotherapy” and still the backbone of most cancer treatment regimens, are increasingly being complemented by or repl...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Mellinghoff, Ingo K. (Editor), Sawyers, Charles L. (Editor) |
Format: | Electronic eBook |
Language: | English |
Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2012.
|
Series: | Current Topics in Microbiology and Immunology,
355 |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Resistance to Tyrosine Kinase Inhibitors
Published: (2016) -
STAT Inhibitors in Cancer
Published: (2016) -
Phosphoinositide 3-kinase in Health and Disease Volume 2 /
Published: (2011) -
Proteases and Their Inhibitors in Cancer Metastasis
Published: (2002) -
Protein Kinase C in Cancer Signaling and Therapy
Published: (2010)